BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9185706)

  • 1. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
    Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
    Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
    Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
    Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
    Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
    Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
    Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
    J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
    Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
    Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive enzyme-linked immunoassay for serum free prostate specific antigen (f-PSA).
    Matsumoto K; Konishi N; Hiasa Y; Kimura E; Takahashi Y; Shinohara K; Samori T
    Clin Chim Acta; 1999 Mar; 281(1-2):57-69. PubMed ID: 10217627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
    Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
    Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
    Jette DC; Kreutz FT; Suresh MR
    Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
    Nilsson O; Peter A; Andersson I; Nilsson K; Grundström B; Karlsson B
    Br J Cancer; 1997; 75(6):789-97. PubMed ID: 9062397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
    Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
    J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
    Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
    J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development and application of monoclonal antibodies against human free prostate specific antigen(f-PSA)].
    Zhang L; Cao L; Wei D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Sep; 34(9):839-844. PubMed ID: 30463658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
    Corey E; Wegner SK; Corey MJ; Vessella RL
    Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.
    Zhou Z; Armstrong EG; Belenky A; Freeman JV; Yeung KK
    J Clin Lab Anal; 1998; 12(4):242-9. PubMed ID: 9671177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antibodies to prostate-specific antigen.
    Nilsson O; Andersson I; Peter A; Karlsson B
    Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
    Corey E; Buhler KR; Vessella RL
    Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
    Paus E; Nustad K; Børmer OP
    Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
    Chen Z; Chen H; Stamey TA
    J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
    Becker C; Wigheden I; Lilja H
    Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.